Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

1.00
+0.125114.30%
Post-market: 0.9950-0.0050-0.50%17:54 EST
Volume:4.60M
Turnover:4.36M
Market Cap:208.65M
PE:-1.44
High:1.02
Open:0.8562
Low:0.8150
Close:0.8749
Loading ...

Q3 2024 Sangamo Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Sangamo Therapeutics Shares Down 9% After Q3 Results, Co Files for Mixed Shelf Offering of up to $500 Mln

THOMSON REUTERS
·
13 Nov 2024

Sangamo Therapeutics Shares Down 11.8% Premarket After Q3 Results, Co Files for Mixed Shelf Offering of up to $500 Mln

THOMSON REUTERS
·
13 Nov 2024

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
13 Nov 2024

BRIEF-Sangamo Therapeutics Files For Mixed Shelf Offering Of Up To $500 Million- SEC Filing

Reuters
·
13 Nov 2024

Sangamo Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Sangamo Therapeutics files for mixed shelf offering

seekingalpha
·
13 Nov 2024

Sangamo Therapeutics Files for Mixed Shelf Offering of up to $500 Mln- SEC Filing

THOMSON REUTERS
·
13 Nov 2024

Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates

Zacks
·
13 Nov 2024

Sangamo: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Sangamo reports Q3 EPS 4c, consensus (3c)

TIPRANKS
·
13 Nov 2024

Sangamo Therapeutics Q3 Operating Expenses USD 38.8 Million

THOMSON REUTERS
·
13 Nov 2024

Sangamo Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Business Wire
·
05 Nov 2024

Sangamo options imply 14.5% move in share price post-earnings

TIPRANKS
·
05 Nov 2024

individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week

Simply Wall St.
·
01 Nov 2024